Tag: pharmaceuticals
-
Engineered Virus Shows Promise in Some Brain Tumors
A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success.
-
Report – Industry Pain, Addiction Drug Efforts Flagging
A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society.
-
Biotechs Collaborate on Immunotherapies in $1.2B Deal
Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers.
-
Neuro Therapy Company Spins-Off, Gains $20.8M Funding
A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors.
-
Open-Source Discovery Seeks Neglected Disease Drug
An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected.
-
Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s
A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease.
-
Radiation, Biotech Companies Partner on Scar Therapy
Two companies taking different approaches to treating keloids — visible raised skin scars — are integrating their therapies to develop an anticipated treatment that removes and prevents the recurrence of these scars.
-
Texas Vaccine Center Expanding R&D
A vaccine research center in Galveston, Texas is expanding its operations to add more basic and preclinical studies that lead to clinical trials resulting in more preventive and therapeutic vaccines.
-
Pharma Maker Crowdsourcing for Drug Delivery Partners
The global pharmaceutical company AstraZeneca is looking for collaborators to develop treatments for disease using nucleic acids delivered with cell-penetrating peptides.
-
Engineered T-Cells Show Extended Leukemia Remission
A clinical trial shows a patient’s immune system cells, modified to add cancer-fighting proteins, can extend high remission among children with a type of leukemia for as long as 12 months, but also with high rates of adverse effects.